Literature DB >> 26084503

The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients.

Nilay Ugurlu1, Selen Bozkurt2, Ali Bacanli3, Ayse Akman-Karakas1, Soner Uzun1, Erkan Alpsoy4.   

Abstract

Our goal was to determine, retrospectively, the occurrence of the symptoms of Behçet's disease in chronological order and the course of the disease. Additionally, probable factors affecting the clinical severity were investigated. A total of 368 patients (171 females and 197 males; aged 41.11 ± 10.9 years) were included in this retrospective cohort study. The chronological order of the clinical manifestations was recorded. Patients were also assessed for clinical severity score. Oral ulcer was the most common manifestation (100 %) followed by genital ulcer (89.4 %), papulopustular lesions (75 %) and articular involvement (60.1 %). Oral ulcer was the most common onset manifestation (66.8 %) followed by genital ulcer (4.9 %), erythema nodosum (3.3 %) and ocular involvement (1.4 %). The duration between the onset symptom and the fulfillment of the diagnostic criteria was 4.67 ± 5.9 years. The duration between the time point of fulfillment of diagnostic criteria and the diagnosis (2.5 ± 2.1 years) was longer in patients having only mucocutaneous lesions (2.8 ± 2.2 years) than in patients having serious organ involvements (1.9 ± 1.6 years; p < 0.01). Serious involvements such as neurological involvement and large vessel involvement had their onsets later. Mean clinical severity score was higher in male patients (5.3 ± 2.1 vs 4.8 ± 1.7; p < 0.05). In logistic regression analysis, male gender (p = 0.03) and increased number of symptoms at diagnosis (p < 0.001, R (2) = 0.73) were found to be significant risk factors for severity. Mucocutaneous lesions, especially oral and/or genital ulcers, usually precede possible serious involvements; therefore, careful follow-up is mandatory. Males with increased number of organ involvements at the diagnosis are associated with more severe disease.

Entities:  

Keywords:  Behçet’s disease; Chronology; Course; Onset manifestation; Severity; Symptom

Mesh:

Year:  2015        PMID: 26084503     DOI: 10.1007/s00296-015-3310-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study.

Authors:  N Pipitone; L Boiardi; I Olivieri; F Cantini; F Salvi; R Malatesta; R La Corte; G Triolo; A Ferrante; D Filippini; G Paolazzi; P Sarzi-Puttini; G Restuccia; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  2004       Impact factor: 4.473

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro.

Authors:  E Alpsoy; V Kodelja; S Goerdt; C E Orfanos; Ch C Zouboulis
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

4.  Behçet disease: evolution of clinical manifestations.

Authors:  Haruko Ideguchi; Akiko Suda; Mitsuhiro Takeno; Atsuhisa Ueda; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Medicine (Baltimore)       Date:  2011-03       Impact factor: 1.889

5.  Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study.

Authors:  E Alpsoy; L Donmez; M Onder; S Gunasti; A Usta; Y Karincaoglu; B Kandi; S Buyukkara; O Keseroglu; S Uzun; U Tursen; M Seyhan; A Akman
Journal:  Br J Dermatol       Date:  2007-08-17       Impact factor: 9.302

6.  Clinical characteristics of Behçet's disease in China.

Authors:  Liao-Yuan Wang; Dong-Bao Zhao; Jun Gu; Sheng-Ming Dai
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

7.  Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece.

Authors:  C C Zouboulis; G Vaiopoulos; N Marcomichelakis; G Palimeris; I Markidou; B Thouas; P Kaklamanis
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

8.  Clinical features of Behcet's disease in Egypt.

Authors:  Manal Mohamed El Menyawi; Hala Mohamed Raslan; Amr Edrees
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

9.  Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4.

Authors:  Nuran Alli; Gunes Gur; Basak Yalcin; Mutlu Hayran
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

10.  New insights in the clinical understanding of Behçet's disease.

Authors:  Sung Bin Cho; Suhyun Cho; Dongsik Bang
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

View more
  8 in total

1.  Do clinical findings of Behçet's disease vary by gender?: A single-center experience from 329 patients.

Authors:  Döndü Üsküdar Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2016-12-01

Review 2.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

3.  Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.

Authors:  Minkyung Han; Yoon Suk Jung; Won Ho Kim; Jae Hee Cheon; Sohee Park
Journal:  J Gastroenterol       Date:  2016-12-27       Impact factor: 7.527

4.  Mortality associated with Behçet's disease in France assessed by multiple-cause-of-death analysis.

Authors:  Emmanuelle David; Mathieu Fauvernier; David Saadoun; Mathieu Gerfaud-Valentin; Delphine Maurcort-Boulch; Pascal Sève; Yvan Jamilloux
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

5.  Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis.

Authors:  Preeyachat Limtong; Kumutnart Chanprapaph; Vasanop Vachiramon; Pintip Ngamjanyaporn
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-08-25

Review 6.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 7.  Neurological complications of Behçet's syndrome.

Authors:  D P Kidd
Journal:  J Neurol       Date:  2017-03-10       Impact factor: 4.849

Review 8.  Experimental Therapeutic Solutions for Behcet's Disease.

Authors:  Burçin Cansu Bozca; Erkan Alpsoy
Journal:  J Exp Pharmacol       Date:  2021-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.